Ionis Pharmaceuticals (IONS) PT Raised to $104 at Oppenheimer

March 25, 2026 10:13 AM

Oppenheimer analyst Jay Olson raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $104.00 (from $96.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found